Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon(Brigham and Women's Hospital), Marc A. Pfeffer(Brigham and Women's Hospital), Brian Claggett(National Heart Lung and Blood Institute), Jerome L. Fleg(National Heart Lung and Blood Institute), Sonja M. McKinlay(New England Research Institutes), Eldrin F. Lewis(Brigham and Women's Hospital), George Sopko(National Heart Lung and Blood Institute), Eileen O’Meara(Montreal Heart Institute), Bertram Pitt(Bayer (Germany)), Nancy K. Sweitzer(National Heart Lung and Blood Institute), Sanjiv J. Shah(National Heart Lung and Blood Institute), Akshay S. Desai(Brigham and Women's Hospital), Inder S. Anand(University of Minnesota)
Cited by 524
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k